From the Departments of Nuclear Medicine.
Urology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Clin Nucl Med. 2021 Jul 1;46(7):579-581. doi: 10.1097/RLU.0000000000003590.
We present a case of clear cell renal cell carcinoma, which demonstrates complementary FDG and prostate-specific membrane antigen (PSMA) uptake on metastases in PET/CT, as an example of tumor heterogeneity. The patient had non-FDG-avid lung and bone metastases with PSMA uptake, whereas metastatic cervical and axillary lymph nodes showed vice versa, and skeletal muscle metastasis to vastus lateralis, which is an unusual region for metastasis, showed both PSMA and FDG positivity. In response assessment, mix response was detected. It seems that 68Ga-PSMA and 18F-FDG may have a complementary role in demonstration of metastasis accurately and assessment of treatment response in clear cell renal cell carcinoma.
我们呈现了一个透明细胞肾细胞癌的病例,该病例在 PET/CT 中显示转移灶同时摄取 FDG 和前列腺特异性膜抗原(PSMA),这是肿瘤异质性的一个例子。该患者有非 FDG 摄取的肺和骨转移灶,PSMA 摄取,而转移性颈和腋窝淋巴结则相反,而股外侧肌转移灶,这是一个不常见的转移部位,同时显示 PSMA 和 FDG 阳性。在反应评估中,检测到混合反应。68Ga-PSMA 和 18F-FDG 似乎在准确显示转移和评估透明细胞肾细胞癌的治疗反应方面具有互补作用。